Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Valentino Ndaba
Be Safe on road
Be safe on the roads: Prevention is better than a hospital ward or coffin.

Safety starts with you, non-compliance ends you. A traffic spike over the Easter holidays does not justify disobeying road rules. The university is counting on all students, both drivers and pedestrians, to continue prioritising safety on the roads.

Don’t be a statistic, take responsibility
The 2018 Preliminary Easter Road Safety Report issued by the Department of Transport, indicated that most accidents were caused by irresponsibility.  “In 2018, human factor contributed 89,5% to crashes as compared to the 74,3% in 2017. The number of jay-walking pedestrians killed on our roads also increased to 38% as compared to 25,2% in 2017,” said Minister of Transport, Blade Nzimande.

The university implores you to play a role in reducing these numbers in 2019.

On driving and cellphones
According to Arrive Alive, the use of communication devices while driving is prohibited. “No person shall drive a vehicle on a public road while holding a cellular or mobile telephone or any other communication device in one or both hands or with any other part of the body, unless such a device is affixed to the vehicle or is part of the fixture in the vehicle.”

Pedestrian duties
Pedestrians are encouraged to practice caution when using sidewalks and while crossing the road. When walking, face oncoming traffic and pay attention to traffic signs so as not to constitute a source of danger to yourself or to traffic.

Safe speed saves lives
A general speed limit of 60 kilometres per hour shall apply to all public roads within urban areas, 100 kilometres per hour on public roads, and 120 kilometres per hour on freeways. Abide by these speed limits, unless stated otherwise by traffic signs.

More tips on drunken driving, wearing seat belts, and other aspects of road safety are easily available on the Arrive Alive website.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept